Clinical Trial Update: Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial data assess the efficacy and safety of NAFT-600 for treating tinea pedis, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinea Pedis

Drugs mentioned

• NAFT-600

Snippet

Sponsor: Merz North America, Inc. | Conditions: Tinea Pedis | Phase 3 | Status: COMPLETED | Results posted: 2013-09-26